<SEC-DOCUMENT>0001193125-25-136361.txt : 20250606
<SEC-HEADER>0001193125-25-136361.hdr.sgml : 20250606
<ACCEPTANCE-DATETIME>20250606082114
ACCESSION NUMBER:		0001193125-25-136361
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250605
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250606
DATE AS OF CHANGE:		20250606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DENTSPLY SIRONA Inc.
		CENTRAL INDEX KEY:			0000818479
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				391434669
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16211
		FILM NUMBER:		251028949

	BUSINESS ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607
		BUSINESS PHONE:		844-546-3722

	MAIL ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENTSPLY INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19930630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENDEX CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d948692d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xray="http://www.dentsplysirona.com/20250605" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-274">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-06-05_to_2025-06-05">0000818479</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="xray-20250605.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-06-05_to_2025-06-05"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818479</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-06-05</xbrli:startDate> <xbrli:endDate>2025-06-05</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-285">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt:datemonthdayyearen" id="ixv-286">June 5, 2025</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-287">DENTSPLY SIRONA Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:stateprovnameen" id="ixv-288">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-289">0-16211</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-290">39-1434669</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">file number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-291">13320 Ballantyne Corporate Place</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-292">Charlotte</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:stateprovnameen" id="ixv-293">North Carolina</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-294">28277-3607</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-295">(844)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-296">848-0137</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:boolballotbox" id="ixv-297">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:boolballotbox" id="ixv-298">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:boolballotbox" id="ixv-299">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:boolballotbox" id="ixv-300">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-301">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-302">XRAY</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:exchnameen" id="ixv-303">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-06-05_to_2025-06-05" format="ixt-sec:boolballotbox" id="ixv-304">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;5, 2025, DENTSPLY SIRONA Inc. (the &#8220;Company&#8221;) entered into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Goldman Sachs&#160;&amp; Co. LLC, as representative of the several underwriters named in Schedule II thereto (collectively, the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters $550,000,000 aggregate principal amount of its 8.375% <span style="white-space:nowrap"><span style="white-space:nowrap">Fixed-to-Fixed</span></span> Reset Rate Junior Subordinated Notes due 2055 (the &#8220;Notes&#8221;), for resale to the public. The Underwriting Agreement contains customary representations and warranties, conditions to closing, indemnification rights, obligations of the parties and termination provisions. The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-286281,</span> dated March&#160;31, 2025 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the sale of the Notes is expected to occur on June&#160;12, 2025, subject to the satisfaction of customary closing conditions contained in the Underwriting Agreement. The net proceeds to the Company from the sale of the Notes, after deducting the Underwriters&#8217; discounts but before deducting the estimated offering expenses payable by the Company, are expected to be approximately $544,500,000. The Company intends to use the proceeds from the sale of the Notes for general corporate purposes, including to repay indebtedness outstanding under the Company&#8217;s existing <span style="white-space:nowrap">364-day</span> $435&#160;million term loan and other short-term indebtedness. A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> and is incorporated herein by reference and incorporated by reference into the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A&#160;press release&#160;dated June&#160;5, 2025 announcing the pricing of the offering of the Notes is attached hereto as Exhibit 99.1. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d948692dex11.htm">Underwriting Agreement, dated June&#160;5, 2025, between DENTSPLY SIRONA Inc. and Goldman Sachs&#160;&amp; Co. LLC, as representative of the several underwriters named in Schedule II thereto </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d948692dex991.htm">Press Release Dated June&#160;5, 2025 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">DENTSPLY SIRONA Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;6, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard C. Rosenzweig</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Richard C. Rosenzweig</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Corporate Development, General Counsel and Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d948692dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DENTSPLY SIRONA INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>US$550,000,000 8.375% Junior Subordinated Notes due 2055 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITING AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;5, 2025
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Manager named in Schedule I hereto </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">for the
Underwriters named in Schedule II hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DENTSPLY SIRONA Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell to the several underwriters named in
Schedule II hereto (the &#147;<B>Underwriters</B>&#148;), for whom you are acting as manager (the &#147;<B>Manager</B>&#148;), the principal amount of each series of its debt securities identified in Schedule I hereto (collectively, the
&#147;<B>Securities</B>&#148;), to be issued under the indenture specified in Schedule I hereto (the &#147;<B>Indenture</B>&#148;) between the Company and the Trustee identified in such Schedule (the &#147;<B>Trustee</B>&#148;).&nbsp;If the firm or
firms listed in Schedule II hereto include only the Manager listed in Schedule I hereto, then the terms &#147;Underwriters&#148; and &#147;Manager&#148; as used herein shall each be deemed to refer to such firm or firms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;) a registration statement, including a
prospectus, (the file number of which is set forth in Schedule&nbsp;I hereto) on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> relating to the securities (the &#147;<B>Shelf Securities</B>&#148;), including the Securities, to be issued from
time to time by the Company.&nbsp;The registration statement as amended to the date of this Agreement, including the information (if any) deemed to be part of the registration statement at the time of effectiveness pursuant to Rule&nbsp;430A or
Rule&nbsp;430B under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), is hereinafter referred to as the &#147;<B>Registration Statement,</B>&#148; and the related prospectus covering the Shelf Securities dated
March&nbsp;31, 2025 in the form first used to confirm sales of the Securities (or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule&nbsp;173 under the Securities Act) is hereinafter
referred to as the &#147;<B>Basic Prospectus</B>.&#148;&nbsp;The Basic Prospectus, as supplemented by the prospectus supplement specifically relating to the Securities in the form first used to confirm sales of the Securities (or in the form first
made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule&nbsp;173 under the Securities Act) is hereinafter referred to as the &#147;<B>Prospectus</B>,&#148; and the term &#147;<B>preliminary
prospectus</B>&#148; means any preliminary form of the Prospectus.&nbsp;For purposes of this Agreement, &#147;<B>free writing prospectus</B>&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act, &#147;<B>Time of Sale
Prospectus</B>&#148; means the documents set forth opposite the caption &#147;Time of Sale Prospectus&#148; in Schedule I hereto, and &#147;<B>road show</B>&#148; means a &#147;bona fide electronic road show&#148; as defined in
Rule&nbsp;433(h)(5)&nbsp;under the Securities Act.&nbsp;As used herein, the terms &#147;Registration Statement,&#148; &#147;Basic Prospectus,&#148; &#147;preliminary prospectus,&#148; &#147;Time of Sale Prospectus&#148; and &#147;Prospectus&#148;
shall include the documents, if any, incorporated by reference therein on the date hereof.&nbsp;The terms &#147;<B>supplement</B>,&#148; &#147;<B>amendment</B>,&#148; and &#147;<B>amend</B>&#148; as used herein with respect to the Registration
Statement, the Basic Prospectus, the Time of Sale Prospectus, any preliminary prospectus or the Prospectus shall include all documents subsequently filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended
(the &#147;<B>Exchange Act</B>&#148;), that are deemed to be incorporated by reference therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <I>Representations and
Warranties</I>.&nbsp;The Company represents and warrants to and agrees with each of the Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company meets the
requirements for use of <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Securities Act. The Registration Statement has become effective; no stop order suspending the effectiveness of the Registration Statement is in effect, and no
proceedings for such purpose or pursuant to Section&nbsp;8A under the Securities Act are pending before or, to the knowledge of the Company, threatened by the Commission.&nbsp;The Company is a well-known seasoned issuer (as defined in Rule&nbsp;405
under the Securities Act) eligible to use the Registration Statement as an automatic shelf registration statement, the Company has not received notice that the Commission objects to the use of the Registration Statement as an automatic shelf
registration statement and the Company has not otherwise ceased to be eligible to use the automatic shelf registration form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i)&nbsp;Each document, if any, filed or to be filed pursuant to the Exchange Act and
incorporated by reference in the Time of Sale Prospectus or the Prospectus complied or will comply when so filed in all material respects with the Exchange Act and the applicable rules&nbsp;and regulations of the Commission thereunder,
(ii)&nbsp;each part of the Registration Statement, when such part became effective, did not contain, and each such part, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, (iii)&nbsp;the Registration Statement as of the date hereof does not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading, (iv)&nbsp;the Registration Statement and the Prospectus comply, and as amended or supplemented, if applicable, will comply in all material respects with the
Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder, (v)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Securities in connection with the offering when the Prospectus is not yet
available to prospective purchasers and at the Closing Date (as defined in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, (vi)&nbsp;each road show, if any, when considered together with the Time of Sale Prospectus, does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and (vii)&nbsp;the Prospectus does not contain
and, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading, except that the representations and warranties set forth in this paragraph do not apply to (A)&nbsp;statements or omissions in the Registration Statement, the Time of Sale Prospectus or the Prospectus based upon information relating to
any Underwriter furnished to the Company in writing by such Underwriter through the Manager expressly for use therein or (B)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility
<FONT STYLE="white-space:nowrap">(Form&nbsp;T-1)</FONT> under the Trust Indenture Act of 1939, as amended (the &#147;<B>Trust Indenture Act</B>&#148;), of the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company is not an &#147;ineligible issuer&#148; in connection with the offering pursuant to Rules&nbsp;164, 405 and 433 under the
Securities Act.&nbsp;Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities
Act and the applicable rules&nbsp;and regulations of the Commission thereunder.&nbsp;Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act or that was prepared by
or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder.&nbsp;Except for the free
writing prospectuses, if any, identified in Schedule I hereto, forming part of the Time of Sale Prospectus, and electronic road shows, if any, each furnished to you before first use, the Company has not prepared, used or referred to, and will not,
without your prior consent, prepare, use or refer to, any free writing prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company has been duly incorporated, is validly
existing as a corporation in good standing under the laws of the State of Delaware, has the corporate power and authority to own its property and to conduct its business as described in the Time of Sale Prospectus and is duly qualified to transact
business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not
reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each
&#147;Significant Subsidiary&#148; (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;1-02(w)&nbsp;under</FONT> the Exchange Act) of the Company has been duly incorporated or formed, is validly existing as a corporation or other legal entity,
in good standing under the laws of the jurisdiction of its incorporation or formation, has the corporate or other power and authority to own its property and to conduct its business as described in the Time of Sale Prospectus and is duly qualified
to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good
standing would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock of each Significant Subsidiary of the Company have been duly and validly
authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and, except as set forth in the Time of Sale Prospectus and the Prospectus, are owned directly or indirectly by the Company, free and clear of all
liens, encumbrances, equities or claims. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) [Reserved]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Base
Indenture has been duly qualified under the Trust Indenture Act.&nbsp;The Base Indenture has been duly authorized, executed and delivered by the Company and constitutes a valid and legally binding agreement of the Company enforceable against the
Company in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&#146; rights generally and equitable principles of general applicability (collectively, the &#147;<B>Enforceability
Exceptions</B>&#148;). The Supplemental Indenture has been duly authorized by the Company, and, at the Closing Date, will have been duly executed and delivered by the Company and will constitute a valid and binding agreement of, the Company,
enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Securities have been duly
authorized by the Company, and, when executed and authenticated in accordance with the provisions of the Indenture and delivered to and paid for by the Underwriters in accordance with the terms of this Agreement, will be valid and binding
obligations of the Company, enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement, the Indenture
and the Securities will not contravene (i)&nbsp;the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company, (ii)&nbsp;any agreement or other instrument binding upon the Company or any of its subsidiaries that
is material to the Company and its subsidiaries, taken as a whole, (iii)&nbsp;any law applicable to the Company, or (iv)&nbsp;any judgment, order or decree of any governmental agency or body having jurisdiction over the Company, except in the case
of clauses (iii)&nbsp;and (iv), for any contravention that would not be reasonably expected to affect the validity of the Securities, or otherwise be reasonably expected to have a material adverse effect on the Company and its subsidiaries, taken as
a whole; and no consent, approval, authorization, order, registration or qualification of or with any governmental agency or body is required to be obtained by the Company for the performance by the Company of its obligations under this Agreement,
the Indenture or the Securities, except for (i)&nbsp;such consents, approvals, authorizations, orders, registrations or qualifications as may be required under state securities or Blue Sky laws and (ii)&nbsp;such consents, approvals, authorizations,
orders, registrations or qualifications that, if not obtained, would not, individually or in the aggregate, reasonably be expected to affect the validity of the Securities or the ability of the Company to consummate the transactions contemplated by
this Agreement, or would not reasonably be expected to result in a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Neither the Company nor any of its subsidiaries is in violation or in default (or, with the giving of notice or lapse of time or both,
would be in default) (&#147;<B>Default</B>&#148;) under its articles of incorporation, charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> and neither the Company nor any of its subsidiaries is (i)&nbsp;in Default under any indenture,
mortgage, loan or credit agreement, deed of trust, note, contract, franchise, lease or other agreement, obligation, condition, covenant or instrument to which the Company or any of its subsidiaries is a party or by which it or any of them may be
bound or to which any of the property or assets of the Company or any of its subsidiaries is subject (each, an &#147;<B>Existing Instrument</B>&#148;) or (ii)&nbsp;in violation of any statute, law, rule, regulation, judgment, order or decree of any
court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or any of its subsidiaries or any of its or their properties, as applicable, except, with respect to clauses
(i)&nbsp;and (ii), for such Defaults or violations as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) There has not occurred any material adverse change, or any development involving a prospective material adverse change, in the condition,
financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The financial statements of the Company (including the related notes and supporting
schedules) included or incorporated by reference in the Time of Sale Prospectus and Prospectus comply as to form in all material respects with the requirements of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act and
present fairly, in all material respects, the financial condition, results of operations and cash flows of the entities purported to be shown thereby at the dates and for the periods indicated and have been prepared in conformity with generally
accepted accounting principles in the United States applied on a consistent basis throughout the periods involved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) There are no legal
or governmental proceedings pending or, to the knowledge of the Company, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject (i)&nbsp;other than
proceedings accurately described in all material respects in the Time of Sale Prospectus and proceedings that would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power
or ability of the Company to perform its obligations under this Agreement, the Indenture or the Securities or to consummate the transactions contemplated by the Time of Sale Prospectus or (ii)&nbsp;that are required to be described in the
Registration Statement or the Prospectus and are not so described; and there are no statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to
the Registration Statement that are not described or filed as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Prior to the date hereof, neither the Company nor, to the
knowledge of the Company, any of its affiliates have taken any action which is designed to or which has constituted or which might cause or result in stabilization or manipulation of the price of any security of the Company in connection with the
offering of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) There are no persons with registration or other similar rights to have any equity or debt securities
registered for sale under the Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been duly waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) No dispute with the employees of the Company or any of its subsidiaries exists and the Company is not aware of any existing or imminent
labor disturbance by the employees of the Company or any of its subsidiaries, in each case that would reasonably be expected to, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Each preliminary prospectus filed as part of the registration statement as originally filed or as part of any amendment thereto, or
filed pursuant to Rule&nbsp;424 under the Securities Act, complied when so filed in all material respects with the Securities Act and the applicable rules&nbsp;and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) The Company is not, and after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as
described in the Prospectus will not be, required to register as an &#147;investment company&#148; as such term is defined in the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) Except as set forth in the Time of Sale Prospectus and the Prospectus, the Company and its subsidiaries (i)&nbsp;are in compliance with
any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<B>Environmental
Laws</B>&#148;), (ii)&nbsp;have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance with all terms and conditions of any such
permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would
not reasonably be expected to, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) Except as set forth in the Time of Sale Prospectus and the Prospectus, there are no costs or liabilities associated with Environmental
Laws (including, without limitation, any capital or operating expenditures required for <FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties) which would reasonably be expected to, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Except as set forth in the Time of Sale Prospectus and the Prospectus, and except as would not reasonably be expected to, individually or
in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole, the Company or its subsidiaries own, possess or have the right to use all patents, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trademarks, service marks, trade names, copyrights, patentable inventions, trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and other intellectual property (collectively, the
&#147;<B>Intellectual Property</B>&#148;) used by the Company or its subsidiaries in, and material to, the conduct of the Company&#146;s or its subsidiaries&#146; business as now conducted or as proposed in the Time of Sale Prospectus and the
Prospectus to be conducted. Except as set forth in the Time of Sale Prospectus and the Prospectus, and except as would not reasonably be expected to, individually or in the aggregate, have a material adverse effect on the Company and its
subsidiaries, taken as a whole, (a)&nbsp;to the Company&#146;s knowledge&nbsp;there is no material infringement by third parties of any of the Company&#146;s Intellectual Property and (b)&nbsp;there are no legal or governmental actions, suits,
proceedings or claims pending or, to the Company&#146;s knowledge, threatened, against the Company (i)&nbsp;challenging the Company&#146;s rights in or to any Intellectual Property owned or used by the Company, (ii)&nbsp;challenging the validity or
scope of any Intellectual Property owned by the Company, or (iii)&nbsp;alleging that the operation of the Company&#146;s business as now conducted infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary
rights of a third party, and the Company is unaware of any facts which would form a reasonable basis for any such claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) Except as
set forth in the Time of Sale Prospectus and the Prospectus, (i)&nbsp;the Company and each subsidiary possess such valid and current certificates, permits, licenses, approvals, consents and other authorizations (collectively, &#147;<B>Government
Licenses</B>&#148;)&nbsp;issued by the appropriate state, federal or foreign regulatory agencies or bodies necessary to conduct their respective businesses, except where the failure to possess such Government Licenses would not reasonably be
expected to, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole and (ii)&nbsp;neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the
revocation or modification of, or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with, any such Government Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected
to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) Except as otherwise disclosed in the Time of
Sale Prospectus and the Prospectus, the Company and each of its subsidiaries has good and marketable title to, or valid rights to lease or otherwise use, all the properties and assets that are material to the respective businesses of the Company and
its subsidiaries, in each case free and clear of any security interests, mortgages, liens, encumbrances, equities, claims and other defects, except such as would not reasonably be expected to, individually or in the aggregate, have a material
adverse effect on the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) The Company and its subsidiaries are insured by recognized, and
to the Company&#146;s knowledge, financially sound institutions with policies in such amounts and with such deductibles and covering such risks as the Company reasonably believes are adequate and customary for their businesses. Except as set forth
in the Time of Sale Prospectus and the Prospectus or as would not reasonably be expected to, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole: (i)&nbsp;all policies of insurance
insuring the Company or any of its subsidiaries or their respective businesses, assets, employees, officers and directors are in full force and effect and (ii)&nbsp;the Company and its subsidiaries are in compliance with the terms of such policies
and instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) Since the date of the latest audited consolidated financial statements of the Company included in the Time of Sale
Prospectus and the Prospectus, there has been no change in internal control over the consolidated financial reporting of the Company that has materially affected, or is reasonably likely to materially affect, the internal control over the
consolidated financial reporting of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) There are no related-party transactions involving the Company or any subsidiary or
any other person required to be described in the Time of Sale Prospectus or the Prospectus that have not been described as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb)
The Company maintains a system of internal control over financial reporting (as such term is defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(f)&nbsp;under</FONT> the Exchange Act) that complies in all material respects with the
requirements of the Exchange Act and has been designed by the Company&#146;s principal executive officer and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Except as disclosed in the Time of Sale Prospectus, (i)&nbsp;since the end of the Company&#146;s most recent audited
fiscal year, there has been no change in the Company&#146;s internal control over financial reporting that has materially affected the Company&#146;s internal control over financial reporting, and (ii)&nbsp;the Company is not aware of any material
weaknesses in its internal control over financial reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) The Company maintains disclosure controls and procedures, as such term is defined in <FONT
STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> of the Exchange Act, that comply in all material respects with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information
relating to the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) (i) PricewaterhouseCoopers LLP, who has audited certain financial statements of the Company, is an independent registered public
accounting firm as required by the Securities Act and the rules&nbsp;and regulations of the Commission thereunder and (ii)&nbsp;Deloitte&nbsp;&amp; Touche LLP, who has audited certain financial statements of the Company, is an independent registered
public accounting firm as required by the Securities Act and the rules&nbsp;and regulations of the Commission thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) (i)
Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or of any of its subsidiaries, is aware of or, has taken any
action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment or giving of money, property, gifts or anything else of value, directly or indirectly, to any &#147;government official&#148; (including any
officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official
or candidate for political office) to influence official action or secure an improper advantage; (ii)&nbsp;the Company and its subsidiaries, and to the knowledge of the Company, its affiliates have conducted their businesses in compliance with
applicable anti-corruption laws and have instituted and maintained policies and procedures reasonably designed to promote and achieve compliance with such laws; (iii)&nbsp;neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or of any of its subsidiaries, has violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or
any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other
applicable anti-bribery or anti-corruption law and (iv)&nbsp;neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in violation of the Foreign Corrupt Practices Act of 1977, as amended, the
OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, the Bribery Act 2010 of the United Kingdom or similar law of any other relevant jurisdiction, or the rules or regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) Except as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its
subsidiaries, taken as a whole, (i)&nbsp;the Company and its subsidiaries and any &#147;employee benefit plan&#148; (as defined in Section&nbsp;3(3)&nbsp;of the Employee Retirement Income Security Act of 1974, as amended, and the regulations and
published interpretations thereunder (collectively, &#147;<B>ERISA</B>&#148;)) established or maintained by the Company, its subsidiaries or their ERISA Affiliates (as defined below) are in compliance in all material respects with ERISA
(&#147;<B>ERISA Affiliate</B>&#148; means, with respect to the Company or a subsidiary, any member of any group of organizations described in Sections 414(b), (c), (m)&nbsp;or (o)&nbsp;of the Internal Revenue Code of 1986, as amended (the
&#147;<B>Internal Revenue Code</B>&#148;), of which the Company or such subsidiary is a member), (ii)&nbsp;no &#147;reportable event&#148; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &#147;employee
benefit plan&#148; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, (iii)&nbsp;no &#147;employee benefit plan&#148; established or maintained by the Company, its subsidiaries or any of their ERISA
Affiliates, if such &#147;employee benefit plan&#148; were terminated, would have any &#147;amount of unfunded benefit liabilities&#148; (as defined under ERISA), (iv)&nbsp;neither the Company, its subsidiaries nor any of their ERISA Affiliates has
incurred or reasonably expects to incur any liability under (A)&nbsp;Title IV of ERISA with respect to termination of, or withdrawal from, any &#147;employee benefit plan,&#148; (B)&nbsp;Sections 412, 4971 or 4975 of the Internal Revenue Code, or
(C)&nbsp;Section&nbsp;4980B of the Internal Revenue Code with respect to the excise tax imposed thereunder, and (v)&nbsp;each &#147;employee benefit plan&#148; established or maintained by the Company, its subsidiaries or any of their ERISA
Affiliates that is intended to be qualified under Section&nbsp;401(a)&nbsp;of the Internal Revenue Code has received a favorable determination letter from the Internal Revenue Service and nothing has occurred, whether by action or failure to act,
which is reasonably likely to cause disqualification of any such employee benefit plan under Section&nbsp;401(a)&nbsp;of the Internal Revenue Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) There is and has been no failure on the part of the Company and, to the knowledge of
the Company, any of the Company&#146;s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the rules&nbsp;and regulations promulgated in connection
therewith, including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) The operations of the
Company and each of its subsidiaries are and have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the
Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and each of its
subsidiaries conduct business, the rules&nbsp;and regulations thereunder and any applicable related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Anti-Money
Laundering Laws</B>&#148;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is
pending or, to the knowledge of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (i)&nbsp;Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company, any director, officer, employee or affiliate of the Company or any of its subsidiaries, is an individual or entity (&#147;<B>Person</B>&#148;) that is owned or controlled by a Person that is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#146;s Office of Foreign Assets
Control (&#147;<B>OFAC</B>&#148;), the United Nations Security Council (&#147;<B>UNSC</B>&#148;), the European Union (&#147;<B>EU</B>&#148;), His Majesty&#146;s Treasury (&#147;<B>HMT</B>&#148;), or other relevant sanctions authority (collectively,
&#147;<B>Sanctions</B>&#148;), nor </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) located, organized or resident in a country or territory that is, or whose
government is, the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic, <FONT
STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic, any other Covered Region of Ukraine identified pursuant to Executive Order 14065, the Crimea region and <FONT STYLE="white-space:nowrap">non-government</FONT> controlled
areas of the Zaporizhzhia and Kherson Regions of Ukraine, Cuba, Iran, North Korea and Syria (each, a &#147;<B>Sanctioned Country</B>&#148;)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other Person: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) to fund or facilitate any activities or business of
or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject or target of Sanctions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) to fund or facilitate any activities of or business in any Sanctioned Country in a manner that constitutes or would
constitute a violation of any Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) in any other manner that will result in a violation of Sanctions by any
Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Company
represents and covenants that, except pursuant to appropriate government authorization or as exempted from such regulation or as permitted by law, since April&nbsp;24, 2019, it has not knowingly engaged in and is not now knowingly engaged in any
dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject or target of Sanctions or with the government of any Sanctioned Country. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) The Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the
date of this Agreement or have requested extensions thereof and have paid all taxes required to be paid thereon (except for cases in which the failure to file or pay would not reasonably be expected to have a material adverse effect on the Company
and its subsidiaries, taken as a whole, or except as currently being contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) The Company and its subsidiaries&#146; information technology assets and equipment,
computers, systems, networks, hardware, software, websites, applications, and databases (collectively, <B>&#147;IT Systems&#148;</B>) are adequate for, and operate and perform in all material respects as required in connection with the operation of
the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained
commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all
personal, personally identifiable, sensitive, confidential or regulated data (<B>&#147;Personal Data&#148;</B>)) used in connection with their businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to
same, except for those that would not reasonably be expected, individually or in the aggregate, to have a material adverse effect on the Company and its subsidiaries, taken as a whole, or that have been remedied without material cost or liability or
the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,
orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT
Systems and Personal Data from unauthorized use, access, misappropriation or modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <I>Agreements to Sell and
Purchase.</I><I></I><I>&nbsp;</I>The Company hereby agrees to issue and sell to the several Underwriters, and each Underwriter, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated,
agrees, severally and not jointly, to purchase from the Company the respective principal amounts of Securities set forth in Schedule&nbsp;II hereto opposite its name at the purchase price set forth in Schedule&nbsp;I hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <I>Public Offering</I>.&nbsp;The Company is advised by you that the Underwriters propose to make a public offering of their respective
portions of the Securities as soon after the Registration Statement and this Agreement have become effective as in your judgment is advisable.&nbsp;The Company is further advised by you that the Securities are to be offered to the public upon the
terms set forth in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <I>Payment and Delivery</I>.&nbsp;Payment for the Securities shall be made to the Company in
Federal or other funds immediately available in New York City on the closing date and time set forth in Schedule&nbsp;I hereto, or at such other time on the same or such other date, not later than the fifth business day thereafter, as may be
designated in writing by you.&nbsp;The time and date of such payment are hereinafter referred to as the &#147;<B>Closing Date</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Securities shall be made against delivery to you on the Closing Date for the respective accounts of the several Underwriters
of the Securities registered in such names and in such denominations as you shall request in writing not later than one full business day prior to the Closing Date, with any transfer taxes payable in connection with the transfer of the Securities to
the Underwriters duly paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <I>Conditions to the Underwriters&#146; Obligations</I>.&nbsp;The several obligations of the Underwriters
are subject to the following conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subsequent to the execution and delivery of this Agreement and prior to the Closing Date:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) no order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such
purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential
downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded the Company or any of the securities of the Company or any of its subsidiaries or in the rating outlook for the
Company by any &#147;nationally recognized statistical rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) there shall not have occurred any change, or any development involving a prospective change, in the condition, financial
or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Prospectus that, in your judgment, is material and adverse and that makes it, in your judgment,
impracticable to market the Securities on the terms and in the manner contemplated in the Time of Sale Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Underwriters shall have received on the Closing Date a certificate, dated the
Closing Date and signed by an executive officer of the Company, to the effect set forth in Section&nbsp;5(a)(i)&nbsp;above and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as
of the Closing Date and that the Company has complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Underwriters shall have received on the Closing Date an opinion of DLA Piper LLP (US), outside counsel for the Company, dated the
Closing Date, in form and substance satisfactory to you, with respect to such matters as you may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Underwriters
shall have received on the Closing Date an opinion of Paul Hastings LLP, counsel for the Underwriters, dated the Closing Date, in form and substance satisfactory to you, with respect to such matters as you may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Underwriters shall have received, on each of the date hereof and the Closing Date, a letter dated the date hereof or the Closing Date,
as the case may be, in form and substance satisfactory to the Underwriters, from (i)&nbsp;PricewaterhouseCoopers LLP and (ii)&nbsp;Deloitte&nbsp;&amp; Touche LLP, independent public accountants of the Company, containing statements and information
of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to certain financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus and
the Prospectus; <I>provided</I> that the letter delivered on the Closing Date shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off</FONT> date&#148; not earlier than two business days prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <I>Covenants of the Company</I>.&nbsp;The Company covenants with each Underwriter as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To furnish to you, without charge, a signed copy of the Registration Statement (including exhibits thereto and documents incorporated by
reference therein) and to deliver to each of the Underwriters during the period mentioned in Section&nbsp;6(e)&nbsp;or 6(f)&nbsp;below, as many copies of the Time of Sale Prospectus, the Prospectus and any supplements and amendments thereto, but
excluding any documents incorporated by reference therein, as you may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Before amending or supplementing the
Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to you a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which you reasonably object. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To furnish to you a copy of each proposed free writing prospectus to be prepared by or on behalf of, used by, or referred to by the
Company and not to use or refer to any proposed free writing prospectus to which you reasonably object. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Not to take any action that
would result in an Underwriter or the Company being required to file with the Commission pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise
would not have been required to file thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Time of Sale Prospectus is being used to solicit offers to buy the Securities
at a time when the Prospectus is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the statements
therein, in the light of the circumstances under which they were made when the Time of Sale Prospectus is delivered to a purchaser, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus
conflicts with the information contained in the Registration Statement then on file, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, promptly to
prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so
amended or supplemented will not, in the light of the circumstances </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
when the Time of Sale Prospectus is delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the
Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will comply with applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If,
during such period after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;under the Securities Act) is
required by law to be delivered in connection with sales by an Underwriter or dealer, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the
light of the circumstances under which they were made when the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;under the Securities Act) is delivered to a purchaser, not misleading, or if it is necessary to amend or
supplement the Prospectus to comply with applicable law, promptly to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers (whose names and addresses you will furnish to the Company) to which
Securities may have been sold by you on behalf of the Underwriters and to any other dealers upon request, either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in the
light of the circumstances when the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;under the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, will
comply with applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such
U.S. jurisdictions as you shall reasonably request; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not so qualified or to take any action that would subject it to service of process
or taxation in any jurisdiction where it is not so subject as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To make generally available (within the meaning of
Rule&nbsp;158(b)&nbsp;under the Securities Act) to the Company&#146;s security holders and to you as soon as practicable an earning statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company
occurring after the date of this Agreement which shall satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Securities Act and the rules&nbsp;and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid
all expenses incident to the performance of its obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses of the Company&#146;s counsel and the Company&#146;s accountants in connection with the registration and
delivery of the Securities under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, any free writing
prospectus prepared by or on behalf of, used by, or referred to by the Company and amendments and supplements to any of the foregoing, including the filing fees payable to the Commission relating to the Securities (within the time required by
Rule&nbsp;456 (b)(1), if applicable), all printing costs associated therewith, and the mailing and delivering of copies thereof to the Underwriters and dealers, in the quantities hereinabove specified, (ii)&nbsp;all costs and expenses related to the
transfer and delivery of the Securities to the Underwriters, including any transfer or other taxes payable thereon, (iii)&nbsp;all filing fees and the reasonable and documented fees and disbursements of counsel to the Underwriters incurred in
connection with the review and qualification of the offering of the Securities by the Financial Industry Regulatory Authority (&#147;<B>FINRA</B>&#148;) (provided such fees and disbursements of counsel payable by the Company pursuant to this clause
(iii)&nbsp;shall not, in the aggregate, exceed $15,000), (iv)&nbsp;any fees charged by the rating agencies for the rating of the Securities, (v)&nbsp;the cost of the preparation, issuance and delivery of the Securities, (vi)&nbsp;the costs and
charges of any trustee, transfer agent, registrar or depositary, (vii)&nbsp;the costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the
Securities, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged
in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and the cost of any aircraft chartered in connection with
the road show, (viii)&nbsp;the document production charges and expenses associated with printing or reproducing this Agreement, the Indenture, closing documents and any other documents in connection with the offering, purchase, sale and delivery of
the Securities and (ix)&nbsp;all other costs and expenses incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section.&nbsp;It is understood, however, that except as provided in
this Section, Section&nbsp;8 entitled &#147;Indemnity and Contribution,&#148; and the last paragraph of Section&nbsp;10 below, the Underwriters will pay all of their costs and expenses, including fees and disbursements of their counsel, transfer
taxes payable on resale of any of the Securities by them and any advertising expenses connected with any offers they may make. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) During the period beginning on the date hereof and continuing to and including the
Closing Date, not to offer, sell, contract to sell or otherwise dispose of any debt securities of the Company or warrants to purchase or otherwise acquire debt securities of the Company substantially similar to the Securities (other than
(i)&nbsp;the Securities, (ii)&nbsp;commercial paper issued in the ordinary course of business or (iii)&nbsp;securities or warrants permitted with the prior written consent of the Manager identified in Schedule I with the authorization to release
this <FONT STYLE="white-space:nowrap">lock-up</FONT> on behalf of the Underwriters). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) To prepare a final term sheet relating to the
offering of the Securities, containing only information that describes the final terms of the Securities or the offering in a form consented to by the Manager, such consent not to be unreasonably withheld or delayed, and to file such final term
sheet with the Commission within the period required by Rule&nbsp;433(d)(5)(ii)&nbsp;under the Securities Act following the date the final terms have been established for the offering of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <I>Covenants of the Underwriters</I>.&nbsp;Each Underwriter severally covenants with the Company not to take any action that would result
in the Company being required to file with the Commission under Rule&nbsp;433(d)&nbsp;under the Securities Act a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company
thereunder, but for the action of the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <I>Indemnity and Contribution</I>.&nbsp;(a)&nbsp;The Company agrees to indemnify
and hold harmless each Underwriter, each person, if any, who controls any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and each affiliate of any Underwriter within the meaning
of Rule&nbsp;405 under the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any documented legal or other expenses reasonably incurred in connection with defending or investigating
any such action or claim) caused by or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any
amendment or supplement thereto, any issuer free writing prospectus as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act, any Company information that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the
Securities Act, any &#147;road show&#148; as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act (a &#147;road show&#148;), or the Prospectus or any amendment or supplement thereto, or arise out of, or are based upon, any omission or alleged
omission to state in (A)&nbsp;the Registration Statement or in any amendment thereto, any material fact required to be stated therein or necessary to make the statements therein not misleading, or (B)&nbsp;any preliminary prospectus, the Prospectus,
the Time of Sale Prospectus, any free writing prospectus or in any amendment or supplement thereto any material fact necessary in order to make the statements therein, in light of the circumstances in which they were made, not misleading, except
insofar as such losses, claims, damages or liabilities are caused by any such untrue statement or omission or alleged untrue statement or omission based upon information furnished to the Company in writing by any Underwriter through you expressly
for use therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also agrees to indemnify and hold harmless MUFG Securities Americas Inc. (&#147;<B>MUFG</B>&#148;), each
person, if any, who controls MUFG within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and each affiliate of MUFG within the meaning of Rule 405 under the Securities Act, from and against any and all
loss, claim, damage, liability or expense, as incurred as a result of MUFG&#146;s participation as a &#147;qualified independent underwriter&#148; within the meaning of FINRA Rule 5121 in connection with the offering of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who sign the
Registration Statement and each person, if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such
Underwriter, but only with reference to information relating to such Underwriter furnished to the Company in writing by such Underwriter through you expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale
Prospectus, any issuer free writing prospectus, road show, or the Prospectus or any amendment or supplement thereto and the Company hereby acknowledges that the only such information furnished to the Company are the statements set forth in the
fourth sentence of the thirteenth paragraph under the caption &#147;Underwriting (Conflicts of Interest)&#148; in the Prospectus. The indemnity agreement set forth in this Section&nbsp;8(b) shall be in addition to any liabilities that each
Underwriter may otherwise have. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In case any proceeding (including any governmental investigation) shall be instituted
involving any person in respect of which indemnity may be sought pursuant to Section&nbsp;8(a)&nbsp;or 8(b), such person (the &#147;<B>indemnified party</B>&#148;) shall promptly notify the person against whom such indemnity may be sought (the
&#147;<B>indemnifying party</B>&#148;) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the
indemnifying party may designate in such proceeding and shall pay the documented fees and disbursements of such counsel reasonably incurred in connection with such proceeding.&nbsp;In any such proceeding, any indemnified party shall have the right
to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or
(ii)&nbsp;the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them.&nbsp;It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be
liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties; <I>provided</I>, that if indemnity may be sought pursuant to the second paragraph of Section&nbsp;8(a) above in
respect of such proceeding, then in addition to such separate counsel of the Underwriters, their affiliates, directors, officers and such control persons of the Underwriters, the Company shall be liable for the fees and expenses of not more than one
separate counsel (together with local counsel (in each jurisdiction)) for MUFG in its capacity as a &#147;qualified independent underwriter&#148;, its affiliates, directors, officers and all persons, if any, who control MUFG within the meaning of
either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act).&nbsp;Such firm shall be designated in writing by the Manager authorized to appoint counsel under this Section&nbsp;set forth in Schedule&nbsp;I hereto, in the case
of parties indemnified pursuant to Section&nbsp;8(a), and by the Company, in the case of parties indemnified pursuant to Section&nbsp;8(b).&nbsp;The indemnifying party shall not be liable for any settlement of any proceeding effected without its
prior written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or
judgment.&nbsp;No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and
indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the extent the indemnification provided for in Section&nbsp;8(a)&nbsp;or 8(b)&nbsp;is unavailable to an indemnified party or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable
by such indemnified party as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters or MUFG in its capacity
as a &#147;qualified independent underwriter&#148;, as the case may be, on the other hand from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause 8(d)(i)&nbsp;above is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to in clause&nbsp;8(d)(i)&nbsp;above but also the relative fault of the Company on the one hand and of the Underwriters or MUFG in its capacity as a &#147;qualified independent
underwriter&#148;, as the case may be, on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.&nbsp;The relative benefits
received by the Company on the one hand and the Underwriters or MUFG in its capacity as a &#147;qualified independent underwriter&#148;, as the case may be, on the other hand in connection with the offering of the Securities shall be deemed to be in
the same respective proportions as the net proceeds from the offering of the Securities (before deducting expenses) received by the Company and the total underwriting discounts and commissions received by the Underwriters or MUFG in its capacity as
a &#147;qualified independent underwriter&#148;, as the case may be, bear to the aggregate initial public offering price of the Securities as set forth in the Prospectus.&nbsp;The relative fault of the Company on the one hand and the Underwriters or
MUFG in its capacity as a &#147;qualified independent underwriter&#148;, as the case may be, on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission
or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters or MUFG in its capacity as a &#147;qualified independent underwriter&#148;, as the case may be, and the parties&#146; relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission.&nbsp;The Underwriters&#146; respective obligations to contribute pursuant to this Section&nbsp;8 are several in proportion to the respective principal
amounts of Securities they have purchased hereunder, and not joint. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company and the Underwriters agree that it would not be just or equitable if
contribution pursuant to this Section&nbsp;8 were determined by pro<I> rata</I> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in Section&nbsp;8(d).&nbsp;The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;8(d)&nbsp;shall be deemed to include, subject to the
limitations set forth above, any documented legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.&nbsp;Notwithstanding the provisions of this Section&nbsp;8, no
Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages that such
Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.&nbsp;No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&nbsp;The remedies provided for in this Section&nbsp;8 are not exclusive and shall not limit any rights or remedies which may
otherwise be available to any indemnified party at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The indemnity and contribution provisions contained in this
Section&nbsp;8 and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this Agreement, (ii)&nbsp;any
investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any affiliate of any Underwriter or by or on behalf of the Company, its officers or directors or any person controlling the Company and
(iii)&nbsp;acceptance of and payment for any of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <I>Termination</I>.&nbsp;The Underwriters may terminate this Agreement
by notice given by you to the Company, if&nbsp;after the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New
York Stock Exchange, the NYSE Amex Stock Exchange or the NASDAQ Global Market, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, (iii)&nbsp;a material disruption in securities settlement, payment or clearance services in the United States or other relevant jurisdiction
shall have occurred, (iv)&nbsp;any moratorium on commercial banking activities shall have been declared by Federal or New York State authorities or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change in
financial markets or any calamity or crisis that, in your judgment, is material and adverse and which, singly or together with any other event specified in this clause&nbsp;(v), makes it, in your judgment, impracticable or inadvisable to proceed
with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale Prospectus or the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <I>Effectiveness; Defaulting Underwriters</I>.&nbsp;This Agreement shall become effective upon the execution and delivery hereof by the
parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the Closing Date, any one or more of the Underwriters shall fail or refuse to purchase Securities that it has or
they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase is not more than
<FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of the Securities to be purchased on such date, the other Underwriters shall be obligated severally in the proportions that the principal amount of Securities set
forth opposite their respective names in Schedule&nbsp;II bears to the aggregate principal amount of Securities set forth opposite the names of all such <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or in such other
proportions as you may specify, to purchase the&nbsp;Securities which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date; <I>provided</I> that in no event shall the principal amount of Securities that
any Underwriter has agreed to purchase pursuant to this Agreement be increased pursuant to this Section&nbsp;10 by an amount in excess of <FONT STYLE="white-space:nowrap">one-ninth</FONT> of such principal amount of Securities without the written
consent of such Underwriter.&nbsp;If, on the Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Securities and the aggregate principal amount of Securities with respect to which such default occurs is more than <FONT
STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of Securities to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities are not made within 36 hours after
such default, this Agreement shall terminate without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company.&nbsp;In any such case either you or the Company shall have the right to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
postpone the Closing Date, but in no event for longer than seven days, in order that the required changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus
or in any other documents or arrangements may be effected.&nbsp;Any action taken under this paragraph shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Agreement shall be terminated by the Underwriters, or any of them, because of any failure or refusal on the part of the Company to
comply with the terms or to fulfill any of the conditions of this Agreement or if for any reason the Company shall be unable to perform its obligations under this Agreement (in each case other than by reason of a default by any of the Underwriters
or as a result of the termination of this Agreement pursuant to clauses (i), (iii), (iv)&nbsp;or (v)&nbsp;of Section&nbsp;9 hereof) the Company will reimburse the Underwriters or such Underwriters as have so terminated this Agreement with respect to
themselves, severally, for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with
this Agreement or the offering contemplated hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <I>Entire Agreement</I>.&nbsp;(a)&nbsp;This Agreement represents the entire
agreement between the Company and the Underwriters with respect to the preparation of any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, the conduct of the offering, and the purchase and sale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company acknowledges that in connection with the offering of the Securities: (i)&nbsp;the Underwriters have acted at arms length, are
not agents of, and owe no fiduciary duties to, the Company or any other person, (ii)&nbsp;the Underwriters owe the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent not superseded by
this Agreement), if any, and (iii)&nbsp;the Underwriters may have interests that differ from those of the Company.&nbsp;The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriters arising from an
alleged breach of fiduciary duty in connection with the offering of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <I>Waiver of Jury Trial</I>.&nbsp;Each of the
parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.
<I>Submission to Jurisdiction</I>. The parties hereby submit to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this
Agreement or the transactions contemplated hereby. Each party waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each party agrees that final judgment in any such suit,
action or proceeding brought in such court shall be conclusive and binding upon such party and may be enforced in any court to the jurisdiction of such party is subject by a suit upon such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <I>Recognition of the U.S. Special Resolution Regimes.</I> (a)&nbsp;In the event that any Underwriter that is a Covered Entity becomes
subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective
under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United State. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special
Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this
Section a &#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#147;Covered Entity&#148; means any of the following: (i)&nbsp;a
&#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or
(iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12
C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;U.S. Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall
Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <I>Counterparts</I>.&nbsp;This Agreement may be signed in two or more counterparts,
which may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
www.docusign.com), each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <I>Applicable Law</I>.&nbsp;This Agreement shall be governed by and construed in accordance with the internal laws of the State of New
York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <I>Headings</I>.&nbsp;The headings of the sections of this Agreement have been inserted for convenience of reference only and
shall not be deemed a part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <I>Notices</I>.&nbsp;All communications hereunder shall be in writing and effective
only upon receipt and if to the Underwriters shall be delivered, mailed or sent to you at the address set forth in Schedule&nbsp;I hereto; and if to the Company shall be delivered, mailed or sent to the address set forth in Schedule&nbsp;I hereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <I>USA Patriot Act</I>.&nbsp;In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT
STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include
the name and address of their respective clients, as well as other information that will allow&nbsp;the underwriters to properly identify their respective clients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">DENTSPLY SIRONA INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Simon Campion</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Simon Campion</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: &#8194;President&nbsp;&amp; CEO</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted as of the date hereof</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS&nbsp;&amp; CO. LLC</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Acting severally on behalf of itself and the several Underwriters named in Schedule II hereto</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Karim Saleh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Karim Saleh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: &#8194;Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to the
Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sole Book-Running Manager</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Manager authorized to release <FONT STYLE="white-space:nowrap">lock-up</FONT> under
Section&nbsp;6(k)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Manager authorized to appoint counsel under Section&nbsp;8(c)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Indenture</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Indenture, dated as of May&nbsp;26, 2020, between the Company and Wells Fargo Bank, National Association, as trustee (the &#147;<B>Base Indenture</B>&#148;), as supplemented by the Second Supplemental Indenture to be dated as of the
Closing Date between the Company and the Trustee (the &#147;<B>Supplemental Indenture</B>&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Computershare Trust Company, N.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Registration Statement File No.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">333-286281</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Time of Sale Prospectus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&#8195;&#8201;Prospectus dated March&nbsp;31, 2025 relating to the Shelf
Securities</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&#8195;&#8201;Preliminary prospectus supplement dated June&nbsp;3, 2025 relating to the
Securities</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&#8195;&#8201;Final term sheet dated June 5, 2025 relating to the Securities (substantially in
the form of Exhibit A)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Securities to be purchased</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.375% Junior Subordinated Notes due 2055 (the &#147;Notes&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aggregate Principal Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$550,000,000 aggregate principal amount of the Notes</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.00% of the principal amount of the Notes, plus accrued interest, if any, from June 12, 2025 for the Notes</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">September&nbsp;12, 2055</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Rate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.375% per annum, accruing from June 12, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Each March&nbsp;12 and September&nbsp;12 commencing September&nbsp;12, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Date and Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;12, 2025 9:00&nbsp;a.m.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Location</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Hastings LLP <BR>The MetLife Building</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">200
Park Avenue <BR>New York, New York 10166</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address for Notices to Underwriters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Goldman Sachs&nbsp;&amp; Co. LLC <BR>200 West Street <BR>New York, New York 10282 <BR>Attention: Registration Department</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address for Notices to the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DENTSPLY SIRONA Inc. <BR>13320 Ballantyne Corporate Place <BR>Charlotte, North Carolina 28277-3607 <BR>Attention: General Counsel <BR>Facsimile: (717) <FONT STYLE="white-space:nowrap">849-4753</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount<BR>of&nbsp;2055 Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">462,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commerz Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><I>Filed pursuant to Rule 433</I><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><I>Free Writing Prospectus dated June&nbsp;5, 2025</I><B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><I>Registration Statement No.: <FONT STYLE="white-space:nowrap">333-286281</FONT></I><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DENTSPLY SIRONA Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Pricing Term Sheet&#151;June 5, 2025 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$550,000,000 8.375% Junior Subordinated Notes due 2055 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issuer:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DENTSPLY SIRONA Inc. (the &#147;<B>Issuer</B>&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Description of Securities:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$550,000,000 8.375% Junior Subordinated Notes due 2055 (the &#147;<B>Notes</B>&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Maturity Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">September&nbsp;12, 2055</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Settlement Date*:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;12, 2025 (T+5)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issue Price:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100.000% of principal amount</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Interest Payment Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to our right to defer the payment of interest on the Notes as described under &#147;Option to Defer Interest Payments&#148; in the
preliminary prospectus supplement, we will pay interest on the Notes semi-annually in arrears on March&nbsp;12 and September&nbsp;12 of each year, beginning on September&nbsp;12, 2025.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Interest on the Notes offered hereby will accrue from June&nbsp;12, 2025.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>First Reset Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">First Reset Date: September&nbsp;12, 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Reset Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">First Reset Date and September&nbsp;12 of every fifth year after 2030</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Interest Rate:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Notes will bear interest (i)&nbsp;from, and including, the original issuance date to, but excluding, September&nbsp;12, 2030 (&#147;<B>First Reset Date</B>&#148;) at a rate of 8.375% per year and (ii)&nbsp;from, and including,
the First Reset Date, during each Reset Period, at a rate per year equal to the Five-year U.S. Treasury Rate as of the most recent Reset Interest Determination Date plus a spread of 4.379%, to be reset on each Reset Date; provided that the interest
rate during any Reset Period will not reset below 8.375% (which equals the initial interest rate on the Notes).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Optional Deferral of Interest:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Up to 10 consecutive years per deferral</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Tax Event Call:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Notes are redeemable, in whole, but not in part, at 100% of the principal amount of the Notes, plus accrued and unpaid interest to, but excluding, the redemption date, by a date no later than 120 days following the occurrence of
a Tax Event.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Rating Agency Event Call:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Notes are redeemable in whole but not in part, at 102% of the principal amount of the Notes, plus accrued and unpaid interest to, but excluding, the redemption date, by a date no later than 120 days following a Rating Agency
Event.</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Optional Redemption Provisions:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">We may redeem the Notes in whole or in part on one or more occasions at a price equal to 100% of the principal amount being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date (i)&nbsp;on any day during
the period commencing on the date that is 90 days prior to the First Reset Date and ending on and including the First Reset Date and (ii)&nbsp;after the First Reset Date, on any interest payment date for the Notes.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Sole Book-Running Manager:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">GOLDMAN SACHS&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">COMMERZ MARKETS LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRUIST SECURITIES, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS
INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CUSIP Number:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">24906PAB5 / US24906PAB58</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Security Ratings**:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Baa3 (Moody&#146;s) / BB (S&amp;P)</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>It is expected that delivery of the Notes will be made against payment therefor on or about June&nbsp;12,
2025, which is the fifth business day following the date hereof (such settlement cycle being referred to as &#147;T+5&#148;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, as amended, trades in
the secondary market generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the business day before the delivery of the notes
under the prospectus supplement will be required, by virtue of the fact that the Notes initially will settle in T+5, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement. Purchasers of the Notes who
wish to trade the Notes should consult their own advisors. </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>**</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to
revision or withdrawal at any time. </B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company has filed a registration statement (including a prospectus and a prospectus
supplement) with the Securities and Exchange Commission (&#147;SEC&#148;) for the offering to which this communication relates. Before you invest, you should read the prospectus and the prospectus supplement and other documents the Company has filed
with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the
offering will arrange to send you the prospectus and the prospectus supplement if you request it by calling Goldman Sachs&nbsp;&amp; Co. LLC toll free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-866-471-2526.</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any disclaimers or other notices that may appear below are not applicable to this
communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system. </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d948692dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dentsply Sirona Prices Offering of $550&nbsp;million of Junior Subordinated Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CHARLOTTE, N.C.,&nbsp;June 5, 2025&nbsp;(GLOBE NEWSWIRE) &#151;&nbsp;DENTSPLY SIRONA Inc.&nbsp;(&#147;Dentsply Sirona&#148; or the &#147;Company&#148;)
(Nasdaq: XRAY) today announced it has priced an offering (the &#147;Offering&#148;) of $550&nbsp;million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the &#147;notes&#148;). The Offering is expected to close on
June&nbsp;12, 2025, subject to customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will bear interest at a fixed rate of 8.375% per year until September&nbsp;12,
2030 (the &#147;First Reset Date&#148;). On and after the First Reset Date, the interest rate per year on the notes for each reset period will be equal to the five-year U.S. Treasury rate as of the most recent reset interest rate determination date,
plus a spread of 4.379%, to be reset on each reset date, provided that the interest rate during any reset period will not be reset below 8.375% (the initial interest rate on the notes). Subject to the Company&#146;s right to defer interest payments,
interest on the notes will be payable semi-annually in arrears on March&nbsp;12 and September&nbsp;12 of each year, commencing on September&nbsp;12, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The net proceeds from the Offering will be approximately $544.5&nbsp;million, after deducting underwriting discounts but before Offering expenses. The Company
intends to use the proceeds from the Offering for general corporate purposes, including to repay indebtedness outstanding under the Company&#146;s existing <FONT STYLE="white-space:nowrap">364-day</FONT> $435&nbsp;million term loan and other
short-term indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC is acting as sole book-running manager for the Offering. PNC Capital Markets LLC, Commerz
Markets LLC, Truist Securities, Inc. and MUFG Securities Americas Inc. are acting as <FONT STYLE="white-space:nowrap">co-managers</FONT> for the Offering. The Offering is being made pursuant to an effective shelf registration statement on file with
the U.S. Securities and Exchange Commission (the &#147;SEC&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offering is being made by means of a prospectus and related preliminary prospectus
supplement only. An electronic copy of the preliminary prospectus supplement, together with the accompanying prospectus, is available on the SEC&#146;s website at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and
accompanying prospectus may be obtained by contacting Goldman Sachs&nbsp;&amp; Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-866-471-2526,</FONT></FONT></FONT> facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-902-9316</FONT></FONT> or by emailing
<FONT STYLE="white-space:nowrap">Prospectus-ny@ny.email.gs.com.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an
offer to purchase the notes or any other securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All statements in this press release that do not directly and exclusively relate to historical facts constitute &#147;forward-looking statements.&#148; Such
statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described
in Part I, Item 1A, &#147;Risk Factors&#148; of the Company&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> and any updating information or other factors which may be described in the Company&#146;s other
filings with the SEC. No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, including regarding the completion of, and the use of proceeds from, the sale of the
notes, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any
events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the
risks identified in the Company&#146;s SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Dentsply Sirona </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dentsply Sirona&nbsp;is the
world&#146;s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide.&nbsp;Dentsply Sirona&nbsp;develops, manufactures, and
markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona&#146;s innovative products provide, high-quality,
effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona&#146;s headquarters is located in&nbsp;Charlotte, North Carolina. The Company&#146;s shares are listed in&nbsp;the United
States&nbsp;on Nasdaq under the symbol XRAY. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andrea Daley </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President,&nbsp;Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1-704-591-8631</FONT></FONT></FONT> <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>InvestorRelations@dentsplysirona.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Press: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marion Par-Weixlberger </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President,&nbsp;Public
Relations&nbsp;&amp; Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+43 676 848414588 <U> </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">marion.par-weixlberger@dentsplysirona.com</FONT></U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>xray-20250605.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/6/2025 12:08:19 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:xray="http://www.dentsplysirona.com/20250605"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.dentsplysirona.com/20250605"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xray-20250605_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xray-20250605_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>xray-20250605_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/6/2025 12:08:20 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>xray-20250605_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 6/6/2025 12:08:20 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="xray-20250605.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DENTSPLY SIRONA Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-16211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">39-1434669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">13320 Ballantyne Corporate Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28277-3607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(844)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-0137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XRAY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d948692d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d948692d8k.htm">d948692d8k.htm</File>
    <File>xray-20250605.xsd</File>
    <File>xray-20250605_lab.xml</File>
    <File>xray-20250605_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d948692d8k.htm": {
   "nsprefix": "xray",
   "nsuri": "http://www.dentsplysirona.com/20250605",
   "dts": {
    "inline": {
     "local": [
      "d948692d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "xray-20250605.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "xray-20250605_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xray-20250605_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-06-05_to_2025-06-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d948692d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-06-05_to_2025-06-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d948692d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.dentsplysirona.com//20250605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-25-136361-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-136361-xbrl.zip
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MS4-I3,AE4"K8IX],(J)(*HQ7T=I Z\.4V>^_M*^FY&HY_90TKP3U92\0 ZH
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M-\6#:^#78$]:2_D/I;"S@SO@YW^OQQ=\* RPA ^,XQ$:ZCE%+<$? Y;(1#>
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M(]20>2&=(\A*Y$,/PCW#M''QH5;M;7&_DZ[GNR>3HA^L+72A@;F!9^]5SS^
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MIVBGPK)I>MU*P.<FT*5O:-:"!('MS(!9 N[*E60LSS-&_U9%GKJJE)XU%K$
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MMBZ%$!+$R$HY8D;%U+U^B6K*U.#?T#!PD.;9!2?,2*RIT6!]%OJ=O;U?\#R
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MX75AU4S2"*SA;&A#"CBY^6N'5GJ(&.:8D$MLLU8MET$*0"S:=L))G\5N'/]
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MT8Q&>3$F? U//-S9I>,YW,('/GGZ(MAY]GAG_>/&EKS 9WUY"RZLU%$>.[)
M>5&1Z4<UDD?$^A&1R<CB7A+=ECD40,;2=1]NO=DZM>O>W=_=>K8+-_L%N4^6
MR.;M".KY4N]^_'1KC]XL'8H<#LI?PYNSXR^UA+UGNUNX>W-NWOU<B:_L:F[.
M0H,U;S'Z1'9"I,XN7E%<X@X/%K?.F%GN8O'GL9WQMSQWW6"P7O/P/Y#N9<TP
M,F^6L!H>C&W7ZO3"=;(62<R>JXGS("P[.#XV?/XZ'X\WW\"#/P:_4:?:LZK
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MV7U )>[2#(== C45_6$TT,UW\?.'MZ_?';P/S@X.?SGS[M,'\%_>'GXMFO2
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M%E?[,ZYQJ;+>V1\]V=SQ^I,W.^L=?1J!.WL1F['7.S_N/:;^Q!$L;8SV=E4
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MY\$!7F<C"@J.7H%(P\!;1".*T?<=1P9>,*SAMI4X$1@N$GC\8_UU=%FG=)F
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MXBDH^J"<ER"ZO"J'CL0#_/7#ZW_"+W\Y?_?VY?\'4$L#!!0    ( *9"QEI
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MY;7P/3CV@KF8GL4*H%])RN0B)2[ U9=K&WZI/("-<I0HX56JFPA[^ /TH0$
M!U,Y3V^]ERZ:5CAB9'R!+C(IVX[\UT"\I#@^8CHV6[#(,1="Z9NF"XXE<HJS
MD5(QX.ALRE98DD1E")EATYU.X0(8X,?N_GZKNT%@C3(> (8BRNG5PL3*S9WF
M#['V$9&9%Z."G W@KYU"/&2\\H&A2B<&WQBH!0<6X"92[ %5*98FRB@'S$36
M93;$78'?(+H!KT5)$=-.R',*KL52K$;@/Z,\7%GD/H?[EKIO0Y2ZTYXO=/+F
MNC]<5AQ3G:NFSV2DCHR=.YGMG.X=[#>1+$Z>T\93\>/^WJ;!!,6A2*P,;&)Q
MF*O7_-2ZO,F/UI7[]KSZUB8Q?A$#P-0'17^6:78, [3$U=4YI0L9' NR\19!
M,;+V<],5QM BWI43V&Q<IM/*+2UQTS\7YS+3.?R"6/FL  ((;)!I4^7^KM<V
M5H>N@(D1%5%!V"'/42)G([W_\.;MVA-QAO=U!'W"#D!JI>*C#HILLU3:5T[Z
M4OG[&7.DPF5C1I8OI&%^@>$4=N'P&<ABJI(Q$#;!/5S@60 +,4Z<C ]C#>/-
M=3ZMU^@PIO.U2]%%>W?15)H)PR_5WI.,M=0TZ)TOL]'W2+A?L<!H(5(E#><>
M2:'IJ9PHPA6<2K@V04Y)-"4<Y*K5%B"]R+*DLDFR:(DSV##!0Y1F.D($9XLJ
MIVT7(582*%%-%$40VY5?DE$40I?47;W58"#/I$Z8V$O6+PU*$3Y7(Z\II>9B
M/I^WO(I:$SN#>@FBDM+F# Q(')Z1L_ZIAF22>NTK.L&:"R)9.\HE&IV8#(N:
M*B_!_%AH-E#D+T5=@-A<'HRRVVZ+CY3;!KE3"@ODUD_6?5[])CKMW4-D'-"Z
MRJ;6J*/' ^<?;JC7'MC2:1X>'#3W7W2:N]W=@T89@)L_Q%A&'E9-GD2IW<YN
M\V4;_^]U#NZ=@ZB'Q54*4,#>2+F/R5K9NVD6OYE%B]]M37P+_FU58K]]9&IJ
M/2AW 7XH!XEZ9%E8 3](5'E!2"[;$B(JK_ <]Y5$X3H"*>=E RA1^2^W@=M
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M7!DR:6<J6VBTC*1MMSC7S=-UL%!N29,GNLVY'5\_C49X=0S&=717#_M:6E3
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M.#8Y,F0X:RYH=&U02P$"% ,4    " "F0L9:9&O_U:Q@  !H]P$ $
M        @ '_$   9#DT.#8Y,F1E>#$Q+FAT;5!+ 0(4 Q0    ( *9"QEI
M0O[$V L  (\B   1              "  =EQ  !D.30X-CDR9&5X.3DQ+FAT
M;5!+ 0(4 Q0    ( *9"QEI(;X>E0P,  %X+   1              "  >!]
M  !X<F%Y+3(P,C4P-C U+GAS9%!+ 0(4 Q0    ( *9"QEH:YV8S6@8  +Y#
M   5              "  5*!  !X<F%Y+3(P,C4P-C U7VQA8BYX;6Q02P$"
M% ,4    " "F0L9:#E3M^[<$  "(*@  %0              @ '?AP  >')A
H>2TR,#(U,#8P-5]P<F4N>&UL4$L%!@     &  8 ?@$  ,F,      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d948692d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xray-20250605.xsd" xlink:type="simple"/>
    <context id="duration_2025-06-05_to_2025-06-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818479</identifier>
        </entity>
        <period>
            <startDate>2025-06-05</startDate>
            <endDate>2025-06-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-274">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-06-05_to_2025-06-05"
      id="Hidden_dei_EntityCentralIndexKey">0000818479</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-285">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-286">2025-06-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-287">DENTSPLY SIRONA Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-288">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-289">0-16211</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-290">39-1434669</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-291">13320 Ballantyne Corporate Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-292">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-293">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-294">28277-3607</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-295">(844)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-296">848-0137</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-297">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-298">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-299">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-300">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-301">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-302">XRAY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-303">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-06-05_to_2025-06-05" id="ixv-304">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
